title: Onset of dermatitis herpetiformis after treatment by interferon and ribavirin for chronic hepatitis C.
authors.forename: Giovanna
authors.initials: G
authors.lastname: Borghi-Scoazec
authors.forename: Philippe
authors.initials: P
authors.lastname: Merle
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Scoazec
authors.forename: Alain
authors.initials: A
authors.lastname: Claudy
authors.forename: Christian
authors.initials: C
authors.lastname: Trepo
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D003874:Dermatitis Herpetiformis / Q000209:etiology* / Q000276:immunology; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008875:Middle Aged; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin